Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Retrophin Inc (RTRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 802,635
  • Shares Outstanding, K 41,437
  • Annual Sales, $ 164,250 K
  • Annual Income, $ -102,680 K
  • 60-Month Beta 0.89
  • Price/Sales 4.89
  • Price/Cash Flow N/A
  • Price/Book 2.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.65
  • Number of Estimates 3
  • High Estimate -0.62
  • Low Estimate -0.69
  • Prior Year -0.56
  • Growth Rate Est. (year over year) -16.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.62 +8.97%
on 05/15/19
19.49 -1.49%
on 06/13/19
+1.25 (+6.96%)
since 05/14/19
3-Month
17.53 +9.53%
on 05/14/19
24.69 -22.24%
on 03/19/19
-3.30 (-14.67%)
since 03/14/19
52-Week
17.53 +9.53%
on 05/14/19
33.00 -41.82%
on 08/31/18
-8.69 (-31.16%)
since 06/14/18

Most Recent Stories

More News
Retrophin to Present at Upcoming Investor Conferences

Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will present at the following upcoming investor conferences in June:

RTRX : 19.20 (-0.88%)
Shares of RTRX Down 16.8% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Retrophin Inc (NASDAQ:RTRX) on April 16th, 2019 at $21.61. In approximately 4 weeks, Retrophin Inc has returned 16.78% as of today's recent price of $17.98.

RTRX : 19.20 (-0.88%)
Retrophin Appoints Sandra E. Poole to Board of Directors

Retrophin, Inc. (NASDAQ: RTRX) today announced the appointment of Sandra E. Poole to the Company's Board of Directors, effective immediately. Ms. Poole brings more than 25 years of biopharmaceutical industry...

RTRX : 19.20 (-0.88%)
Retrophin (RTRX) Reports Q1 Loss, Misses Revenue Estimates

Retrophin (RTRX) delivered earnings and revenue surprises of -75.00% and -5.72%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

RTRX : 19.20 (-0.88%)
Retrophin: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Retrophin Inc. (RTRX) on Tuesday reported a loss of $41 million in its first quarter.

RTRX : 19.20 (-0.88%)
Retrophin, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2019 / Retrophin, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 4:30 PM Eastern Time.

RTRX : 19.20 (-0.88%)
Retrophin to Report First Quarter 2019 Financial Results

Retrophin, Inc. (NASDAQ: RTRX) today announced it will report first quarter 2019 financial results on Tuesday, May 7, 2019 after the close of the U.S. financial markets. The Company will host a conference...

RTRX : 19.20 (-0.88%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Tg Therapeutics (TGTX , CYTK , RTRX , LGND , SPPI )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

TGTX : 7.26 (+1.97%)
CYTK : 9.54 (-4.02%)
RTRX : 19.20 (-0.88%)
Retrophin (RTRX) Reports Q4 Loss, Misses Revenue Estimates

Retrophin (RTRX) delivered earnings and revenue surprises of -10.53% and -0.98%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

RTRX : 19.20 (-0.88%)
Detailed Research: Economic Perspectives on KAR Auction Services, Spectrum Brands, Vertex Pharmaceuticals, The Kraft Heinz, comScore, and Retrophin -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of KAR Auction Services, Inc (NYSE:KAR),...

SPB : 58.28 (-1.97%)
SCOR : 8.36 (-2.34%)
KHC : 30.31 (-0.33%)
VRTX : 170.22 (+0.79%)
KAR : 60.26 (-1.73%)
RTRX : 19.20 (-0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade RTRX with:

Business Summary

Retrophin is a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. The Company's approved products include Chenodal', Cholbam, and Thiola',...

See More

Key Turning Points

2nd Resistance Point 19.63
1st Resistance Point 19.42
Last Price 19.20
1st Support Level 18.99
2nd Support Level 18.77

See More

52-Week High 33.00
Fibonacci 61.8% 27.09
Fibonacci 50% 25.26
Fibonacci 38.2% 23.44
Last Price 19.20
52-Week Low 17.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar